Neurology

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).

Welcome to the EMJ review of the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2022 Congress, which took place in Amsterdam, the Netherlands, on 26th–28th October. This review showcases key abstract presentations, including an analysis on the value of serum neurofilament light chain in predicting multiple sclerosis diagnosis and future disability.

Welcome to our latest issue of EMJ Neurology, our updates on the latest research and expert insights in the field. Just some of the featured articles include a review of adiposity and neurological disorders, an analysis of sex-related differences in stroke presentation, and a rare case of paediatric NMDAR encephalitis.

This infographic explores depression in patients with epilepsy, focusing on the impact of the COVID-19 pandemic. Questioning what healthcare professionals can do to help, this infographic analyses the epidemiology of depression and notes the differences between patients with controlled epilepsy and those with drug-resistant epilepsy.

This symposium review of presentations made at the World Muscle Society (WMS) 2021 Virtual Congress draws a spotlight upon two monogenic neuromuscular diseases: spinal muscular atrophy (SMA) and Duchenne muscular dystrophy. 

‘Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations’ reviews…

In this supplement text to EMJ Neurology, two key opinion leaders, Mark S Freedman and Lluís Ramió-Torrentà, discussed the current approaches and challenges in the assessment of disease activity and progression in relapsing-remitting multiple sclerosis (RRMS). The interviewees also provide their perspectives on this topic of disease activity and progression in patients with RRMS, including an overview of the measurement tools that can be utilised in clinical practice.

The global burden of Alzheimer’s disease is increasing exponentially, affecting both the developed and developing world. Valuable…